These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3286963)

  • 1. [Effect of ethmozin on the blood circulation system in patients with cardiac rhythm disorders].
    Glezer MG; Kurbanova ZIu
    Kardiologiia; 1988 Feb; 28(2):97-8. PubMed ID: 3286963
    [No Abstract]   [Full Text] [Related]  

  • 2. [First clinical application of a new Soviet anti-arrhythmia preparation, a diethylamine derivative of ethmozin, in patients with various disorders of cardiac rhythm].
    Shugushev KhKh; Smetnev AS; Rozenshtraukh LV; Kaverina NV
    Kardiologiia; 1982 May; 22(5):71-5. PubMed ID: 7047857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology of ethacizin].
    Kaverina NV; Skoldinov AP; Senova ZP; Gritsenko AN; Lyskovtsev VV
    Farmakol Toksikol; 1985; 48(5):43-9. PubMed ID: 3908141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a new anti-arrhythmia preparation ethacizin (a diethylamine analog of ethmozin) on the heart conduction system in different forms of heart rhythm disorder].
    Smetnev AS; Shugushev KhKh; Rozenshtraukh LV; Shevchenko NM
    Ter Arkh; 1983; 55(1):92-5. PubMed ID: 6340241
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemodynamic effect of ethmozine and its diethylamine analog ethacizin on central hemodynamics in patients with various functional states of the myocardium].
    Ageev FT; Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):113-5. PubMed ID: 3890894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of ethmozin and Ritmilen on microcirculatory hemostasis in patients with heart rhythm disorders].
    Grigor'ev GI; Petrova TR
    Farmakol Toksikol; 1986; 49(5):94-7. PubMed ID: 3533622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of ethacizine on the heart conduction system and the indicators of central hemodynamics].
    Gorshkov VA; Nesvetov VN; Kesarev GV; Sherashov VS; Mamaev VI
    Sov Med; 1991; (8):9-11. PubMed ID: 1763379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
    Goldshteĭne GKh; Chichkanov GG
    Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ethacizin: pharmacologic properties and prospects for clinical application].
    Kaverina NV; Lyskovtsev VV; Senova ZP; Grigor'eva EK
    Kardiologiia; 1984 May; 24(5):52-7. PubMed ID: 6748472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A preliminary report on the antiarrhythmic effect of ethmozine].
    Fang WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Jun; 16(3):154-5. PubMed ID: 3065022
    [No Abstract]   [Full Text] [Related]  

  • 12. [The characteristics of the action of ethacizine and its combination with digoxin and glutamic acid on the hemodynamic indices and myocardial contractile capacity in patients with a heart rhythm disorder].
    Zapevina VV; Poliakova LA; Nikolaeva SA
    Ter Arkh; 1990; 62(9):51-4. PubMed ID: 1980753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A symposium: Pharmacological management of ventricular arrhythmias--current status in the role of moricizine HCl. October 19-22, 1989, Scottsdale, Arizona. Proceedings.
    Am J Cardiol; 1990 Feb; 65(8):1D-71D. PubMed ID: 2407087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Initial results of clinical research on a tabletted form of ethacizin (the diethylamino analog of ethmozine) in ventricular arrhythmias].
    Rozenshtraukh LV; Shugushev KhKh; Smetnev AS; Mukharliamov NM; Ponomarenko EL
    Kardiologiia; 1985 Mar; 25(3):43-50. PubMed ID: 2582177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview: moricizine--can it meet the challenge?
    Morganroth J; Bigger JT
    Am J Cardiol; 1990 Feb; 65(8):1D-2D; discussion 68D-71D. PubMed ID: 2407086
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders].
    Smetnev AS; Ponomarenko EL; Koltunova MI; Shugushev KhKh
    Kardiologiia; 1987 May; 27(5):24-6. PubMed ID: 2443743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membrane-stabilizing preparations in the treatment of patients with heart rhythm disorders of different etiologies].
    Vizir AD; Grigor'eva ZE; Stepanova IV; Vizir VA
    Vrach Delo; 1991 Oct; (10):32-6. PubMed ID: 1803742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double-blind research on the anti-arrhythmia effect of ethacizin].
    Gorbachev VV; Pristrom MS; Sytyĭ VP; Mrochek AG; Odinets VS
    Klin Med (Mosk); 1986 Apr; 64(4):41-5. PubMed ID: 3523032
    [No Abstract]   [Full Text] [Related]  

  • 19. [The antiarrhythmic drug Etmozine in the light of new findings].
    Mádle A
    Vnitr Lek; 1987 Sep; 33(9):810-5. PubMed ID: 3314125
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of Bonnecor on clinical manifestations, bioelectric cardiac activity and cardiac hemodynamics in patients with acute myocardial infarction and chronic ischemic heart disease].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Klin Med (Mosk); 1990 Feb; 68(2):44-6. PubMed ID: 2335944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.